U.S. launch of cancer drug faces delays
AstraZeneca PLC's experimental cancer drug Iressa appears to buy lung-cancer patients a few extra months could mean that some terminally ill people may not live to see it on the market. Iressa has
AstraZeneca PLC's experimental cancer drug Iressa appears to buy lung-cancer patients a few extra months could mean that some terminally ill people may not live to see it on the market. Iressa has